ShockWave

$160.22 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About ShockWave

Shockwave Medical, Inc. is a medical device company. The Company is engaged in the development of Intravascular Lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular and heart valve disease. Its products for the treatment of Peripheral Artery disease (PAD) includes Shockwave M5 IVL catheter (M5 catheter) and Shockwave S4 IVL catheter (S4 catheter). Its product for the treatment of Coronary Artery disease (CAD) is Shockwave C2 IVL catheter (C2 catheter). M5 catheter is a five-emitter catheter for use in its IVL System in medium vessels for the treatment of above-the-knee PAD. S4 catheter is a four-emitter catheter for use in its IVL System in small vessels for the treatment of below-the-knee PAD. C2 catheter is a two-emitter catheter for use in its IVL System for the treatment of CAD.

Stock Analysis

last close $162.34
1-mo return -17.3%
3-mo return 10.1%
avg daily vol. 657.25T
52-week high 249.73
52-week low 113.36
market cap. $5.8B
forward pe 75
annual div. -
roe 12.3%
ltg forecast -
dividend yield -
annual rev. $299M
inst own. 92.1%
baraka

Subscribe now for daily local and international financial news

Subscribe